Skip to main content
Start triage

Start triage first, then route to emergency care.

Need urgent help? Start triage first, then route to emergency care.

Roxee Medication Guide

Acepromazine

Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.

Both Reference complete FDA data linked Rx required Liquid (Solution) Multiple FDA sponsors Official label facts Owner quick guide first

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Reference facts
Reference refreshed
Aug 6, 2026, 7:47 p.m.

These are the reference facts Roxee uses on browse cards and quick facts.

FDA applications
FDA application data refreshed
Aug 6, 2026, 7:47 p.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports
Safety data refreshed
Aug 6, 2026, 7:49 p.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:47 PM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed Aug 6, 2026, 7:47 PM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Illustration placeholder
Acepromazine

Acepromazine

Drug type: Generic ingredient • Generic profile No FDA branded products linked

Both Liquid (Solution) Rx required 100% reference complete

Species: Both

Manufacturer: Multiple FDA sponsors

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Acepromazine

PromAce Injectable can be used as an aid in controlling intractable animals during examination, treatment, grooming, x-ray and minor surgical procedures; to alleviate itching as a result of skin irritation; as an antiemetic to control vomiting associated with motion sickness. PromAce Injectable can be used as an aid in controlling fractious animals during examination,treatment, loading and transportation. Particularly useful when used in conjunction with local anesthesia for firing, castration, neurectomy, removal of skin tumors, ocular surgery and applying casts. Used as an aid in controlling intractable animals during examination, treatment, grooming, x-ray, and minor surgical procedures; to alleviate itching as a result of skin irritation; as an antlemetic to control comiting associated with motion sickness. Species commonly shown: Both, Dog, Horse.

Generic name
Acepromazine
Brand names
Acepromazine Maleate Injection, Acepromazine Maleate Tablets
Manufacturer
Multiple FDA sponsors
Species
Both, Dog, Horse, Cat
Dosage forms
Liquid (Solution), Tablet
Prescription
Prescription required
Completeness
100%
Validation
Complete
Brand names
Acepromazine Maleate Injection Acepromazine Maleate Tablets
Dosage forms
Liquid (Solution) Tablet

Indications / Uses

PromAce Injectable can be used as an aid in controlling intractable animals during examination, treatment, grooming, x-ray and minor surgical procedures; to alleviate itching as a result of skin irritation; as an antiemetic to control vomiting associated with motion sickness. PromAce Injectable can be used as an aid in controlling fractious animals during examination,treatment, loading and transportation. Particularly useful when used in conjunction with local anesthesia for firing, castration, neurectomy, removal of skin tumors, ocular surgery and applying casts. Used as an aid in controlling intractable animals during examination, treatment, grooming, x-ray, and minor surgical procedures; to alleviate itching as a result of skin irritation; as an antlemetic to control comiting associated with motion sickness.

Warnings / Contraindications

Not for use in animals intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • Not for use in animals intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Side Effects

Top reported reactions (openFDA): Vomiting, Lack of efficacy - NOS, Death, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Lethargy (see also Central nervous system depression in Neurological).

FAQ

Both, Dog, Horse, Cat

Yes. Roxee shows this as prescription-only.

Liquid (Solution), Tablet

Add to My Pet's Medications

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

As an aid in tranquilization and as a preanesthetic agent in dogs. Acepromazine Maleate Tablets can be used as an aid in controlling intractable animals during examination, treatment, grooming, x-ray and minor surgical p...

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • wobbly/unsteady walking (1 reports)
  • Death by euthanasia (1 reports)
  • Death (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

Regulatory restrictions are shown in Vet View.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?

Next actions

Research brief

Medication Research Insights

A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.

Source Backed Signals

What to know

Evidence-backed context Limited

Roxee has limited cited overview evidence for Acepromazine; use the official documents and your veterinarian's instructions for product-specific decisions.

Source: openFDA case USA-USFDACVM-2026-US-004595
Safety signal coverage Reported signals

32 tracked reaction signals; 32 reported cases; 22 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.

Source: openFDA case USA-USFDACVM-2026-US-004595
Interpretation guardrail Not causation

Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.

Evidence tension

Stronger signal Label / review

Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.

Source: openFDA case USA-USFDACVM-2026-US-004595
Weaker signal Reported data

Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.

Reaction signal map

Most reported reactions Top terms

Unsteady walking (ataxia) (1 reports), Death by euthanasia (1 reports), Death (1 reports), Cyst NOS (1 reports), Cyanosis (1 reports)

Body systems represented Signal grouping

Digestive (2), Skin & allergy (2), Neurologic (1), Behavior (2)

Explore supporting adverse reports

Species and breed lens

Species represented in reports Species lens

Cat (17 reports), Dog (15 reports)

Breed metadata in reports Metadata only

Domestic Shorthair (3), Crossbred Canine/dog (1), Retriever - Labrador (1), Siberian Husky (1). These are report metadata, not proof that a breed is at higher risk.

What your vet may verify

Fit for this patient Vet check

Verify whether Acepromazine fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.

Evidence limitations Evidence review

Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.

What to watch next

Watch list Owner-safe

wobbly/unsteady walking, Death by euthanasia, Death

Call sooner if Escalation

Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.

Bottom line: Use this Acepromazine brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.
Vet source depth
  1. openFDA case USA-USFDACVM-2026-US-004595 · adverse_reaction · adverse reactions
  2. Contraindication source · fda_animal_drugs · warnings contraindications
  3. FDA application profile · official_label · quick facts
  4. FDA application profile · official_label · quick facts
  5. Medication usage source · fda_animal_drugs · quick facts
  6. FOI · document · documents
  7. SPL · document · documents
  8. FOI · document · documents

Evidence

Review status / Updated / Sources

Review status: Clinical reviewer not listed

Updated: April 15, 2026, 10:04 AM UTC

Safety & side effects

Side effects to monitor:

  • wobbly/unsteady walking
  • Death by euthanasia
  • Death

Most reported reactions:

  • Unsteady walking (ataxia) (1 reports)
  • Death by euthanasia (1 reports)
  • Death (1 reports)
Explore reported case details

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.

Vet Fast Scan

Source-backed clinical checkpoints for quick review.

FDA-labeled species
Cat, Dog, Horse
Indication / use
As an aid in tranquilization and as a preanesthetic agent in dogs. Acepromazine Maleate Tablets can be used as an aid in controlling intractable animals during examination, treatm…
Form / route / dose
Form: Liquid (Solution), Tablet
Route: Intramuscular, Intravenous, Oral, Subcutaneous
Confirm product label and patient-specific plan.
Warnings
  • High: Not for use in animals intended for food. Federal law restricts this drug to use by or on the order of a licensed veter…
Adverse-event caveat
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Multiple FDA sponsors
Form: Liquid (Solution), Tablet
Identifiers:
ANADA: 200319 ANADA: 200361 ANADA: 200757 NADA: 135299 NADA: 15030 NADA: 32702 NDC Package: 0010-3827-01 NDC Package: 0010-6703-01 NDC Package: 0010-6703-02 NDC Package: 0010-6704-01 NDC Package: 0010-6704-02 NDC Package: 10695-181-10 NDC Package: 11695-0093-1 NDC Package: 11695-0093-5 NDC Package: 11695-0094-1 NDC Package: 11695-0094-5 NDC Package: 11695-0095-5 NDC Package: 11695-7033-1 NDC Package: 11695-7033-2 NDC Package: 11695-7034-1
Source metadata:

Warnings / Contraindications

Not for use in animals intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • High: Not for use in animals intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Reported case explorer

Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.

Clear filters
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Stored reports
22
Matching reports
22
Active filters
0
Reset
Showing up to 50 matching reports.

USA-USFDACVM-2026-US-014482

Received 2026-03-27 · MSK · MSK

Serious
Species
Dog
Breed
Crossbred Canine/dog
Size / weight
25-49 lb (12.247 Kilogram)
Age
1-3 years (3 Year)
Sex
Male Intact
Region
USA
Reactions
Injection site painRestlessnessEmesis (multiple)
Body systems
OtherDigestive
Outcomes
Ongoing

USA-USFDACVM-2026-US-012958

Received 2026-03-18 · MSK · MSK

Serious
Species
Dog
Breed
Retriever - Labrador
Size / weight
50-99 lb (29.211 Kilogram)
Age
4-7 years (7 Year)
Sex
Female Unknown
Region
USA
Reactions
AtaxiaHind limb paresisProprioception deficitPain NOSPartial lack of efficacy
Body systems
NeurologicOtherEffectiveness
Outcomes
Ongoing

USA-USFDACVM-2026-US-013318

Received 2026-03-16 · MSK · MSK

Non-serious
Species
Dog
Breed
Siberian Husky
Size / weight
50-99 lb (25.855 Kilogram)
Age
8+ years (15 Year)
Sex
Male Neutered
Region
USA
Reactions
Neurological signs NOSAtaxiaDisorientationKnucklingNeutrophiliaAbnormal cytology
Body systems
NeurologicOther
Outcomes
Ongoing

USA-USFDACVM-2026-US-011414

Received 2026-03-13 · MSK · MSK

Non-serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (4.54 Kilogram)
Age
8+ years (17 Year)
Sex
Female Neutered
Region
USA
Reactions
HyperactivityUrinary retentionConstipationRestlessnessDysphoriaNot sleeping
Body systems
Other
Outcomes
Recovered/Normal

USA-USFDACVM-2026-US-010510

Received 2026-03-05 · MSK · MSK

Serious
Species
Dog
Breed
Chihuahua
Size / weight
10-24 lb (8.709 Kilogram)
Age
4-7 years (5 Year)
Sex
Male Neutered
Region
USA
Reactions
PaddlingNystagmusTachycardiaTachypnoea
Body systems
Other
Outcomes
Recovered/Normal

USA-USFDACVM-2026-US-009585

Received 2026-03-03 · MSK · MSK

Non-serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (2.6 Kilogram)
Age
Under 1 year (0.51 Year)
Sex
Male Neutered
Region
USA
Reactions
Application site abscessApplication site scabInjection site abscessInjection site scabDefect Unknown/Not Specified
Body systems
Other
Outcomes
Recovered/Normal

USA-USFDACVM-2026-US-009573

Received 2026-03-03 · MSK · MSK

Non-serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (6.123 Kilogram)
Age
4-7 years (6.92 Year)
Sex
Male Neutered
Region
USA
Reactions
Application site swellingApplication site scabApplication site bleedingInjection site scabInjection site swellingInjection site bleeding
Body systems
Skin & allergyOther
Outcomes
Ongoing

USA-USFDACVM-2026-US-008769

Received 2026-02-28 · MSK · MSK

Serious
Species
Cat
Breed
Russian
Size / weight
Under 10 lb (4.3 Kilogram)
Age
8+ years (19 Year)
Sex
Male Neutered
Region
USA
Reactions
Not drinkingNot eatingDullnessAnaemia NOSCardiac disorder NOSHeart murmurPale mucous membraneAtaxiaOliguriaRenal failureDeath by euthanasiaInappetenceLethargy (see also Central nervous system depression in Neurological)AscitesThird eyelid protrusionLateral recumbencyAcute renal failureDehydrationProlonged capillary refill timeHyperglycaemiaSplenic neoplasm NOSHead bobbingElevated blood urea nitrogen (BUN)Elevated creatinineAbnormal radiograph findingAzotaemiaDecreased packed cell volume (PCV)DullHypernatraemia
Body systems
OtherNeurologic
Outcomes
Euthanized

USA-USFDACVM-2026-US-009973

Received 2026-02-27 · MSK · MSK

Serious
Species
Dog
Breed
Crossbred Canine/dog
Size / weight
50-99 lb (34.019 Kilogram)
Age
8+ years (10.5 Year)
Sex
Male Neutered
Region
USA
Reactions
Not eatingWalking difficultyPantingSeizure NOSDeathIntentional misuse
Body systems
OtherNeurologic
Outcomes
Died

USA-USFDACVM-2026-US-009436

Received 2026-02-19 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
Under 10 lb (4.2 Kilogram)
Age
Under 1 year (5 Month)
Sex
Male Intact
Region
USA
Reactions
Vomiting
Body systems
Digestive
Outcomes
Recovered/Normal

USA-USFDACVM-2026-US-011611

Received 2026-02-14 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (6.3 Kilogram)
Age
4-7 years (6 Year)
Sex
Male Neutered
Region
USA
Reactions
DeathDullNot himself/herselfHead pressingHypotensionUnresponsive to stimuli
Body systems
Other
Outcomes
Died

USA-USFDACVM-2026-US-005800

Received 2026-02-02 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (6.3 Kilogram)
Age
4-7 years (6 Year)
Sex
Male Neutered
Region
USA
Reactions
DeathDullNot himself/herselfHead pressingHypotensionUnresponsive to stimuli
Body systems
Other
Outcomes
Died

USA-USFDACVM-2026-US-004595

Received 2026-01-26 · MSK · MSK

Serious
Species
Dog
Breed
Bulldog - American
Age
4-7 years (5.16 Year)
Sex
Female Neutered
Region
USA
Reactions
Other abnormal test result NOSTooth disorderBumps on skinCyst NOSAllergy NOSLoose stoolCrustLocal erythemaLickingDermal noduleOtitis NOSScratchingSneezingDermatitisBehavioural disorder NOSHair loss NOSNasal dischargeWeight gainSkin disorders NOSAlopecia generalAbnormal cytologyLocalised pain NOS (see other SOCs for specific pain)Salivary stainingAnxietySkin lumpMast cell tumourReddening of the skinSkin lesion NOSLack of efficacy (bacteria) - Ehrlichia
Body systems
OtherBehaviorSkin & allergyDigestiveEffectiveness
Outcomes
Ongoing

USA-USFDACVM-2026-US-000241

Received 2026-01-07 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Longhair
Size / weight
10-24 lb (5 Kilogram)
Age
1-3 years (3 Year)
Sex
Male Neutered
Region
USA
Reactions
Unresponsive to stimuliHeart block NOSBradycardia
Body systems
Other
Outcomes
Recovered/Normal

USA-USFDACVM-2025-US-075461

Received 2025-12-29 · MSK · MSK

Serious
Species
Dog
Breed
Greyhound
Size / weight
50-99 lb (27.3 Kilogram)
Age
8+ years (9 Year)
Sex
Female Neutered
Region
USA
Reactions
Lack of efficacy - NOSUnrelated death
Body systems
EffectivenessOther
Outcomes
Euthanized

USA-USFDACVM-2025-US-075440

Received 2025-12-29 · MSK · MSK

Serious
Species
Dog
Breed
['Retriever - Golden', 'Poodle - Standard']
Size / weight
50-99 lb (25.5 Kilogram)
Age
4-7 years (5 Year)
Sex
Male Neutered
Region
USA
Reactions
Lack of efficacy - NOSUnrelated death
Body systems
EffectivenessOther
Outcomes
Euthanized

USA-USFDACVM-2025-US-075367

Received 2025-12-29 · MSK · MSK

Serious
Species
Dog
Breed
Crossbred Canine/dog
Size / weight
25-49 lb (17.7 Kilogram)
Age
8+ years (14 Year)
Sex
Male Neutered
Region
USA
Reactions
Lack of efficacy - NOSUnrelated death
Body systems
EffectivenessOther
Outcomes
Euthanized

USA-USFDACVM-2025-US-073109

Received 2025-12-11 · MSK · MSK

Serious
Species
Dog
Breed
Bulldog - French
Size / weight
25-49 lb (12.927 Kilogram)
Age
8+ years (8 Year)
Sex
Female Unknown
Region
USA
Reactions
TachycardiaApnoeaCyanosisCardiac arrestDeathAngioedema
Body systems
Other
Outcomes
Died

USA-USFDACVM-2025-US-072459

Received 2025-12-01 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (4.536 Kilogram)
Age
1-3 years (2 Year)
Sex
Male Neutered
Region
USA
Reactions
Seizure NOSDeath by euthanasia
Body systems
NeurologicOther
Outcomes
Euthanized

USA-USFDACVM-2025-US-070754

Received 2025-11-26 · MSK · MSK

Non-serious
Species
Dog
Breed
Spitz - German Pomeranian
Size / weight
Under 10 lb (3.221 Kilogram)
Age
8+ years (1 Year)
Sex
Male Neutered
Region
USA
Reactions
Vomiting
Body systems
Digestive
Outcomes
Recovered/Normal

USA-USFDACVM-2025-US-070682

Received 2025-11-18 · MSK · MSK

Serious
Species
Cat
Breed
Domestic Mediumhair
Size / weight
10-24 lb (4.82 Kilogram)
Age
4-7 years (6.08 Year)
Sex
Female Neutered
Region
USA
Reactions
FibrosarcomaDecreased activityHissingInjection site lumpBehavioural disorder NOSTooth disorderGingivitisNeoplasia NOSLeucocytosis NOSSkin inflammation NOSAbnormal radiograph findingAbnormal cytology
Body systems
OtherBehavior
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-070955

Received 2025-10-22 · MSK · MSK

Serious
Species
Cat
Breed
Cat (unknown)
Size / weight
Under 10 lb (1.09 Kilogram)
Age
Under 1 year (4 Month)
Sex
Mixed Unknown
Region
USA
Reactions
Increased heart rateIncreased respiratory rateLack of efficacy - NOS
Body systems
OtherEffectiveness
Outcomes
Recovered/Normal

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
22
Species represented
2
Grouped by Body System
Digestive (2) · Loss of appetite, Appetite loss Skin & allergy (2) · Application site swelling, Alopecia general Neurologic (1) · Unsteady walking (ataxia) Behavior (2) · Behavioral disorder (unspecified), Anxiety Other (25) · Death by euthanasia, Death, Cyst NOS
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Neurologic 1 Dog 1
Other 1 Cat 1
Other 1 Cat 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Cat 1
Other 1 Dog 1

Species coverage: Cat (17) Dog (15)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Neurologic Dog Serious - 1
Digestive Cat Non-serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Non-serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Behavior Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Skin & allergy Cat Non-serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Digestive Dog Serious - 1
Other Dog Serious - 1
Behavior Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Skin & allergy Dog Serious - 1
Other Dog Serious - 1
Other Cat Non-serious - 1
Other Cat Non-serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Dog Non-serious - 1
Other Dog Serious - 1
Source metadata:

Source Documents

The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.

Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.

Full source previews and metadata remain in the veterinary/professional layer.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

0
No official label or package insert links yet.

SPL

3

FOI

3

Acepromazine Maleate Tablets

SPL · SPL

FDA Structured Product Label

Acepromazine Maleate Tablets

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
ZyVet Animal Health, Inc.
ANADA
200-757
Status
RX
Form
Tablet
Route
Oral
Species
Dog
Composition / specifications
10 mg and 25 mg tablet sizes

Dogs

Indication

As an aid in tranquilization and as a preanesthetic agent in dogs. Acepromazine Maleate Tablets can be used as an aid in controlling intractable animals during examination, treatment, grooming, x-ray and minor surgical procedures.

Dosage

0.25 – 1.0 mg/lb of body weight. Dosage may be repeated as required.

Acepromazine Maleate Injection

SPL · SPL

FDA Structured Product Label

Acepromazine Maleate Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Boehringer Ingelheim Animal Health USA Inc.
ANADA
200-361
Status
RX
Form
Liquid (Solution)
Route
Intramuscular, Intravenous, Subcutaneous
Species
Dog • Horse • Cat
Composition / specifications
Each milliliter of sterile aqueous solution contains 10 milligrams of acepromazine maleate.

Cats

Indication
It is used as a tranquilizer.
Dosage
0.5 to 1.0 milligram per pound of body weight. The drug is administered intravenously, intramuscularly or subcutaneously with the dosage individualized depending upon the degree of tranquilization required.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dogs

Indication
It is used as a tranquilizer.
Dosage
0.25 to 0.5 milligram per pound of body weight. The drug is administered intravenously, intramuscularly or subcutaneously with the dosage individualized depending upon the degree of tranquilization required.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication
It is used as a tranquilizer.
Dosage
2.0 to 4.0 milligrams per 100 pounds of body weight. The drug is administered intravenously, intramuscularly or subcutaneously with the dosage individualized depending upon the degree of tranquilization required.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Acepromazine Maleate Injection

SPL · SPL

FDA Structured Product Label

Acepromazine Maleate Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Elanco US Inc.
ANADA
200-319
Status
RX
Form
Liquid (Solution)
Route
Subcutaneous, Intravenous, Intramuscular
Species
Dog • Horse • Cat
Composition / specifications
Each milliliter of sterile aqueous solution contains 10 milligrams of acepromazine maleate.

Dogs

Indication
It is used as a tranquilizer.
Dosage
0.25 to 0.5 milligram per pound of body weight. The drug is administered intravenously, intramuscularly or subcutaneously with the dosage individualized depending upon the degree of tranquilization required.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Indication
It is used as a tranquilizer.
Dosage
0.5 to 1.0 milligram per pound of body weight. The drug is administered intravenously, intramuscularly or subcutaneously with the dosage individualized depending upon the degree of tranquilization required.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Horses

Indication
It is used as a tranquilizer.
Dosage
2.0 to 4.0 milligrams per 100 pounds of body weight. The drug is administered intravenously, intramuscularly or subcutaneously with the dosage individualized depending upon the degree of tranquilization required.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FOI Summary oA 200-757 Approved August 31, 2023.pdf

FOI · FOI

ucm059294.pdf

FOI · FOI

ucm061778.pdf

FOI · FOI

Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:47 PM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed Aug 6, 2026, 7:47 PM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Official (FDA)
Identity: Generic ingredient • No FDA branded products linked
No official FDA brand rows linked yet for this ingredient.
Case-reported brands (openFDA): MSK
Catalog species: Both FDA-labeled species: Cat, Dog, Horse
Rx/OTC: RX
Form/route: Liquid (Solution), Tablet Intramuscular, Intravenous, Oral, Subcutaneous
Applications: ANADA 200-757 • ANADA 200-361 • ANADA 200-319
Documents: 3 (FOI: 3) • SPL: 3 Label highlights Official documents
Safety (openFDA)
Top reactions: Dog 58 Cat 67 View
Case summaries: 22 (showing 8) View
openFDA reports are unverified and do not prove causation.

Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • Not for use in animals intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Contraindication, High)
Top reaction signals
Unsteady walking (ataxia) (1) Death by euthanasia (1) Death (1) Cyst NOS (1) Cyanosis (1) Crust (1) Cardiac disorder NOS (1) Cardiac arrest (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
ANADA: 200319 ANADA: 200361 ANADA: 200757 NADA: 135299 NADA: 15030 NADA: 32702 NDC Package: 0010-3827-01 NDC Package: 0010-6703-01 NDC Package: 0010-6703-02 NDC Package: 0010-6704-01 NDC Package: 0010-6704-02 NDC Package: 10695-181-10 NDC Package: 11695-0093-1 NDC Package: 11695-0093-5 NDC Package: 11695-0094-1 NDC Package: 11695-0094-5 NDC Package: 11695-0095-5 NDC Package: 11695-7033-1 NDC Package: 11695-7033-2 NDC Package: 11695-7034-1 NDC Package: 11695-7034-2 NDC Package: 13985-582-25 NDC Package: 13985-582-50 NDC Package: 13985-583-10
Package NDC Product NDC Form / Route Status
0010-3827-01 0010 -
0010-6703-01 0010 -
0010-6703-02 0010 -
0010-6704-01 0010 -
0010-6704-02 0010 -
10695-181-10 10695 -
11695-0093-1 11695 -
11695-0093-5 11695 -
11695-0094-1 11695 -
11695-0094-5 11695 -
11695-0095-5 11695 -
11695-7033-1 11695 -
11695-7033-2 11695 -
11695-7034-1 11695 -
11695-7034-2 11695 -
13985-582-25 13985 -
13985-582-50 13985 -
13985-583-10 13985 -
13985-583-50 13985 -
13985-587-50 13985 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 10 Clinical 5 Manufacturer 0 Marketing 0
Current Field Facts
  • contraindications: Not for use in animals intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Clinical, 2026-04-15)
  • contraindications: Not for use in animals intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Clinical, 2026-04-11)
  • side_effects: Top reported reactions (openFDA): Vomiting, Lack of efficacy - NOS, Death, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, … (Clinical, 2026-04-11)
  • usage: PromAce Injectable can be used as an aid in controlling intractable animals during examination, treatment, grooming, x-ray and minor surgical procedures; to al… (Clinical, 2026-04-15)
  • usage: PromAce Injectable can be used as an aid in controlling intractable animals during examination, treatment, grooming, x-ray and minor surgical procedures; to al… (Clinical, 2026-04-11)
  • contraindications: Not for use in animals intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Official, 2026-04-22)
  • contraindications: Not for use in animals intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Official, 2026-02-12)
  • side_effects: Top reported reactions (openFDA): Vomiting, Lack of efficacy - NOS, Death, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, … (Official, 2026-04-22)
  • side_effects: Top reported reactions (openFDA): Vomiting, Lack of efficacy - NOS, Death, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, … (Official, 2026-04-15)
  • side_effects: Top reported reactions (openFDA): Vomiting, Lack of efficacy - NOS, Death, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, … (Official, 2026-02-12)
  • usage: PromAce Injectable can be used as an aid in controlling intractable animals during examination, treatment, grooming, x-ray and minor surgical procedures; to al… (Official, 2026-04-22)
  • usage: PromAce Injectable can be used as an aid in controlling intractable animals during examination, treatment, grooming, x-ray and minor surgical procedures; to al… (Official, 2026-02-12)
Recent Revisions
  • side_effects updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published
Acepromazine Maleate Tablets
RX
Acepromazine Maleate
Tablet Oral
ZyVet Animal Health, Inc. ANADA 200-757 Approved Sep 1, 2023
Acepromazine Maleate Injection
RX
Acepromazine Maleate
Liquid (Solution) Intramuscular, Intravenous, Subcutaneous
Boehringer Ingelheim Animal Health USA Inc. ANADA 200-361 W May 3, 2023
Acepromazine Maleate Injection
RX
Acepromazine Maleate
Liquid (Solution) Subcutaneous, Intravenous, Intramuscular
Elanco US Inc. ANADA 200-319 Approved Jun 1, 2016

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Species: Dog
Composition / specifications
10 mg and 25 mg tablet sizes
Dogs
Indication

As an aid in tranquilization and as a preanesthetic agent in dogs. Acepromazine Maleate Tablets can be used as an aid in controlling intractable animals during examination, treatment, grooming, x-ray and minor surgical procedures.

Dosage

0.25 – 1.0 mg/lb of body weight. Dosage may be repeated as required.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Horse • Cat
Composition / specifications
Each milliliter of sterile aqueous solution contains 10 milligrams of acepromazine maleate.
Cats
Indication
It is used as a tranquilizer.
Dosage
0.5 to 1.0 milligram per pound of body weight. The drug is administered intravenously, intramuscularly or subcutaneously with the dosage individualized depending upon the degree of tranquilization required.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
It is used as a tranquilizer.
Dosage
0.25 to 0.5 milligram per pound of body weight. The drug is administered intravenously, intramuscularly or subcutaneously with the dosage individualized depending upon the degree of tranquilization required.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
It is used as a tranquilizer.
Dosage
2.0 to 4.0 milligrams per 100 pounds of body weight. The drug is administered intravenously, intramuscularly or subcutaneously with the dosage individualized depending upon the degree of tranquilization required.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Horse • Cat
Composition / specifications
Each milliliter of sterile aqueous solution contains 10 milligrams of acepromazine maleate.
Dogs
Indication
It is used as a tranquilizer.
Dosage
0.25 to 0.5 milligram per pound of body weight. The drug is administered intravenously, intramuscularly or subcutaneously with the dosage individualized depending upon the degree of tranquilization required.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
It is used as a tranquilizer.
Dosage
0.5 to 1.0 milligram per pound of body weight. The drug is administered intravenously, intramuscularly or subcutaneously with the dosage individualized depending upon the degree of tranquilization required.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
It is used as a tranquilizer.
Dosage
2.0 to 4.0 milligrams per 100 pounds of body weight. The drug is administered intravenously, intramuscularly or subcutaneously with the dosage individualized depending upon the degree of tranquilization required.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Usage

PromAce Injectable can be used as an aid in controlling intractable animals during examination, treatment, grooming, x-ray and minor surgical procedures; to alleviate itching as a result of skin irritation; as an antiemetic to control vomiting associated with motion sickness. PromAce Injectable can be used as an aid in controlling fractious animals during examination,treatment, loading and transportation. Particularly useful when used in conjunction with local anesthesia for firing, castration, neurectomy, removal of skin tumors, ocular surgery and applying casts. Used as an aid in controlling intractable animals during examination, treatment, grooming, x-ray, and minor surgical procedures; to alleviate itching as a result of skin irritation; as an antlemetic to control comiting associated with motion sickness.

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

Not for use in animals intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Loss of appetite (1) • Cat Appetite loss (1) • Dog

Showing top 5 for Digestive.

Skin & allergy
Application site swelling (1) • Cat Alopecia general (1) • Dog

Showing top 5 for Skin & allergy.

Neurologic
Unsteady walking (1) • Dog

Showing top 5 for Neurologic.

Behavior
Behavioral disorder (1) • Cat Anxiety (1) • Dog

Showing top 5 for Behavior.

Other
Death by euthanasia (1) • Cat Death (1) • Cat Cyst NOS (1) • Dog Cyanosis (1) • Dog Crust (1) • Dog
Show more (20)
Constipation (1) • Cat Cardiac disorder NOS (1) • Cat Cardiac arrest (1) • Dog Bumps on skin (1) • Dog Bradycardia (1) • Dog Azotaemia (1) • Cat Ascites (1) • Cat Application site scab (1) • Cat Application site bleeding (1) • Cat Application site abscess (1) • Cat Apnoea (1) • Dog Angioedema (1) • Dog Anaemia NOS (1) • Cat Allergy NOS (1) • Dog Administration error NOS (1) • Cat Adipsia (1) • Cat Acute renal failure (1) • Cat Abnormal radiograph finding (1) • Cat Abnormal electrocardiogram (1) • Dog Abnormal cytology (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, Crossbred Canine/dog, Male, 3 year, 12.247 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Injection site pain, Restlessness, Vomiting • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-014482
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 3.00 Year
  • Weight: 12.247 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Unassigned
Reactions Reported:
Injection site pain Restlessness Vomiting
Outcomes: Ongoing

Dog, Retriever - Labrador, Female, 7 year, 29.211 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Unsteady walking (ataxia), Hind limb paresis, Proprioception deficit, Pain NOS, Partial lack of efficacy • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-012958
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 7.00 Year
  • Weight: 29.211 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Unsteady walking (ataxia) Hind limb paresis Proprioception deficit Pain NOS Partial lack of efficacy
Outcomes: Ongoing

Dog, Siberian Husky, Male, 15 year, 25.855 kilogram • Drug: MSK, Unknown • Reactions: Neurological signs NOS, Unsteady walking (ataxia), Disorientation, Knuckling, Neutrophilia… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-013318
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Male
  • Age: 15.00 Year
  • Weight: 25.855 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Neurological signs NOS Unsteady walking (ataxia) Disorientation Knuckling Neutrophilia Abnormal cytology
Outcomes: Ongoing

Cat, Domestic Shorthair, Female, 17 year, 4.54 kilogram • Drug: MSK, Unknown • Reactions: Hyperactivity, Urinary retention, Constipation, Restlessness, Dysphoria… • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2026-US-011414
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Female
  • Age: 17.00 Year
  • Weight: 4.540 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Hyperactivity Urinary retention Constipation Restlessness Dysphoria Not sleeping
Outcomes: Recovered/Normal

Dog, Chihuahua, Male, 5 year, 8.709 kilogram • Drug: MSK, Liquid, Unknown • Reactions: Paddling, Nystagmus, Tachycardia, Tachypnoea • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2026-US-010510
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 5.00 Year
  • Weight: 8.709 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Liquid
Reactions Reported:
Paddling Nystagmus Tachycardia Tachypnoea
Outcomes: Recovered/Normal

Cat, Domestic Shorthair, Male, 0.51 year, 2.6 kilogram • Drug: MSK, Intramuscular • Reactions: Application site abscess, Application site scab, Injection site abscess, Injection site scab, Defect Unknown/Not Specified • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2026-US-009585
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 0.51 Year
  • Weight: 2.600 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Intramuscular
Reactions Reported:
Application site abscess Application site scab Injection site abscess Injection site scab Defect Unknown/Not Specified
Outcomes: Recovered/Normal

Cat, Domestic Shorthair, Male, 6.92 year, 6.123 kilogram • Drug: MSK, Intramuscular • Reactions: Application site swelling, Application site scab, Application site bleeding, Injection site scab, Injection site swelling… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-009573
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 6.92 Year
  • Weight: 6.123 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Intramuscular
Reactions Reported:
Application site swelling Application site scab Application site bleeding Injection site scab Injection site swelling Injection site bleeding
Outcomes: Ongoing

Cat, Russian, Male, 19 year, 4.3 kilogram • Drug: MSK, Unknown, Dose: 10 Milligram per animal • Reactions: Not drinking, Not eating, Dullness, Anaemia NOS, Cardiac disorder NOS… • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2026-US-008769
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 19.00 Year
  • Weight: 4.300 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Dose: 10 Milligram per animal
Reactions Reported:
Not drinking Not eating Dullness Anaemia NOS Cardiac disorder NOS Heart murmur Pale mucous membrane Unsteady walking (ataxia) Oliguria Renal failure Death by euthanasia Inappetence Tiredness (lethargy) Ascites Third eyelid protrusion Lateral recumbency Acute renal failure Dehydration Prolonged capillary refill time Hyperglycaemia Splenic neoplasm NOS Head bobbing Elevated blood urea nitrogen Elevated creatinine Abnormal radiograph finding Azotaemia Decreased packed cell volume Dull Hypernatraemia
Outcomes: Euthanized

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.